Monitoring of patients with hematological malignancies after anticancer therapy
The number of patients achieved continuous complete remission constantly increasing as a result of pediatric hematology development. Improvement and optimization of treatment protocols includes both efficacy increase and toxicity reduction, but today any type therapy is associated with risk of long-...
Saved in:
| Main Authors: | A. E. Rudneva, E. E. Ilyina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-01-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of hematological malignancies in Africa: A systematic review and meta-analysis
by: Zewudu Mulatie, et al.
Published: (2025-03-01) -
Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting
by: Samuel Davis, et al.
Published: (2025-06-01) -
Trend analysis of hematological tumors in adolescents and young adults from 1990 to 2019 and predictive trends from 2020 to 2044: A Global Burden of Disease study
by: Linlin Huang, et al.
Published: (2024-09-01) -
CK2 in the spotlight: decoding its role in hematological malignancies and therapeutic applications
by: Zhaoyi Cai, et al.
Published: (2025-05-01) -
Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approach
by: Kathryn R. Tringale, et al.
Published: (2025-03-01)